Trial · NCT05756764
Anti-obesity Pharmacotherapy and Inflammation
NCT05756764, Active not recruiting, Louisiana State University Health Sciences Center in New Orleans
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Anti-obesity Pharmacotherapy and Inflammation. Trials, record NCT05756764. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05756764
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Anti-obesity Pharmacotherapy and Inflammation
- NCT number
- NCT05756764
- Status
- Active not recruiting
- Enrollment
- 30 participants, estimated
- Lead sponsor
- Louisiana State University Health Sciences Center in New Orleans
- Conditions
- Obesity
- Interventions
- Semaglutide, Phentermine-Topiramate combination, Phentermine, Tirzepatide, Topiramate, Diethylpropion, Naltrexone/Bupropion, Liraglutide
- First posted
- 2023-03-06
- Last updated
- 2025-09-09
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | weight loss | baseline and 24 weeks | Weight Loss Percentage (Pounds lost divided by starting weight (in pounds) multiplied by 100) |
| Primary | MDSC in peripheral blood | baseline and 24 weeks | Changes in number of MDSC in blood |
| Primary | Levels of lipids in circulation | baseline and 24 weeks | Changes in concentration (mg/dL) of each type of lipids: LDL-Cholesterol, triglycerides, and free fatty acids |
| Secondary | Systemic inflammation measured by C-reactive protein levels | baseline and 24 weeks | Changes in concentration (mg/L) of C-reactive protein in serum |
| Secondary | Systemic inflammation measured by adipokines levels in circulation | baseline and 24 weeks | Changes in concentration (pg/mL) of interleukin 6 (IL-6), tumor-necrosis factor alpha (TNFa) and leptin in plasma |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| U24DK132740 | The Louisiana Center for Advancing Uplifting Scientists Careers in Health, Nutrition, Obesity, and Diabetes Research (LAUNCHED) | NEWTON, ROBERT LEE; KATZMARZYK, PETER TODD | LSU PENNINGTON BIOMEDICAL RESEARCH CTR | NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES | 2022 to 2025 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05756764
GET https://conductscience.org/api/trials/v1/NCT05756764/registered